FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Mar. 12, 2025 — A sedentary lifestyle such as watching TV (two or more hours daily) may be a key factor in the risk of developing heart and blood vessel diseases, according to an analysis of ...

Heart diseases and blood circulation conditions, including their risk factors, symptoms, and treatment.

(Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions.

It is a common type of what's called paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia that often affects younger adults resulting in symptoms of dizziness or trouble breathing. The ...

Reena Caprario ate a healthy diet, exercised almost every day, maintained a good weight and felt well while doing cardio, so she never worried about the possibility of a heart attack.

Deciding when to go to the hospital for a rapid heart depends on your health history and how you are feeling overall. A heart rate of 100 beats per minute (bpm) or higher, also known as tachycardia, ...

17/865,697, covers the repeat dose regimen used in the RAPID Phase 3 study that evaluated CARDAMYST in PSVT and proposed for ... with complex and life-altering heart conditions.

First-degree ventricular (heart) block affects the electrical signal that makes the heart beat. It causes a delay in a portion of the heart beat and may lead to a slow heart beat. Healthcare ...

One of the things I’ve learned over the years is that the people in your heart will make you cry—that’s just the way the waterworks work. But nothing approached the way I cried when Rob died.

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...